Legend Biotech to Participate in the Jefferies Global Healthcare Conference
May 29 2024 - 7:00AM
Business Wire
Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a
global leader in cell therapy, today announced that Ying Huang,
Ph.D., the company’s Chief Executive Officer, will participate in a
fireside chat at the Jefferies Global Healthcare Conference in New
York, NY on Thursday, June 6, 2024, at 10:30 a.m. ET.
The live webcast will be available to investors and other
interested parties by accessing the Investor Relations
section of Legend’s website. The webcast replay will be available
approximately 48 hours after the webcast.
ABOUT LEGEND BIOTECH
Legend Biotech is a global biotechnology company dedicated to
treating, and one day curing, life-threatening diseases.
Headquartered in Somerset, New Jersey, we are developing advanced
cell therapies across a diverse array of technology platforms,
including autologous and allogeneic chimeric antigen receptor
T-cell, gamma-delta T cell (gd T) and natural killer (NK)
cell-based immunotherapy. From our three R&D sites around the
world, we apply these innovative technologies to pursue the
discovery of cutting-edge therapeutics for patients worldwide.
Learn more at www.legendbiotech.com and follow us on X (formerly
Twitter) and LinkedIn.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240529662563/en/
INVESTOR CONTACT: Jessie Yeung Tel: (732) 956-8271
jessie.yeung@legendbiotech.com
PRESS CONTACT: Mary Ann Ondish Tel: (914) 552-4625
media@legendbiotech.com
Legend Biotech (NASDAQ:LEGN)
Historical Stock Chart
From May 2024 to Jun 2024
Legend Biotech (NASDAQ:LEGN)
Historical Stock Chart
From Jun 2023 to Jun 2024